HOME › DRUGS › MOMELOTINIB
ACTIVE SUBSTANCE / INN

MOMELOTINIB

Brand name(s): Omjjara
EMA LISTED
AUTHORISED
Splenomegaly;Myeloproliferative Disorders
ACTIVE SUBSTANCE
Momelotinib
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OmjjaraGlaxoSmithKline Trading Services LimitedAuthorised25/01/2024Splenomegaly;Myeloproliferative Disorders

FULL INTELLIGENCE ON MOMELOTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →